Clinical Trial

PulseMagic™ TrueForce™ PAF NMPA Study

Study acronym: PFATrueForce
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This clinical investigation is intended to demonstrate safety and effectiveness of the PulseMagic™ TrueForce™ Ablation Catheter and the PulseMagic™Pulse Field Ablation (PFA) Generator, and Columbus™ 3D EP Navigation System with Pulsed Field Ablation Software for the treatment of symptomatic, recurrent, drug refractory paroxysmal atrial fibrillation (PAF).
Trial Details
NCT Number NCT07720557
Lead Sponsor Shanghai MicroPort EP MedTech Co., Ltd.
Conditions Atrial Fibrillation (AF), Paroxysmal AF, Drug Refractory Paroxysmal Atrial Fibrillation, Atrial Arrhythmia
Enrollment 150 participants
Start Date 2026-07-10
Primary Completion 2028-07-01 (estimated)
Study Completion 2028-11-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-22